Animal studies also provide evidence to support BCR-ABL as the oncogenic cause of CML as it was shown to induce a myeloproliferative syndrome that closely resembles the chronic phase of human CML4. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.